Neisseria meningitidis composition and methods thereof
US10196429B2 · kind B2 · utility
10Cited by
80References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2017 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Jun 22, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the invention relates to a non-lipidated and non-pyruvylated Neisseria meningitidis serogroup B subfamily A A12 polypeptide. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.